Reply To:
Name - Reply Comment
Last Updated : 2023-09-22 22:45:00
Fri, 22 Sep 2023 Today's Paper
Researchers at the Institute of Biochemistry, Molecular Biology and Biotechnology (IBMBB) of University of Colombo (UoC) have devised a new technique to target and kill breast cancer stem cells.
These stem cells are considered to form the root of many cancers, that are hard to treat with available chemo and radio therapy treatment. The researchers developed a nanotechnology assisted targeted delivery system containing a natural compound isolated from an endemic plant from Sri Lanka and a protein which can selectively bind with a protein present in the cell membrane of breast cancer stem cells.
This research is led by Dr. Sameera R. Samarakoon at the Institute of Biochemistry, Molecular Biology and Biotechnology (IBMBB) and Professor Kamani Tennekon, Professor Neelika Malavige, Professor Nedra Karunarathne, Dr. Meran Keshawa Ediriweera and were helped by Uma Rajagopalan and Amal Hulangamuwa to achieve the desired research goals.
As we all know cancer is a dreadful disease with limited treatment options. A number of researches are being carried out worldwide to develop a permanent cure for cancer. Unfortunately, a permanent treatment options hasn’t been developed yet. Cancer stem cells are found in tumours and possess unique characteristics. They are resistant to chemo and radio therapies and can travel unnoticed by our immune system to form new tumours at any location in the body, which is known as metastasis.
Research in the field of cancer stem cells is uphill as specifically targeting cancer stem cells has been tough,” Dr. Samarakoon said. “There are even limited detection methods available to detect these cancer stem cells” said Dr. Samarakoon while adding that a significant improvement has been made in research work they conduct to identify novel plant derived natural compounds which can target breast cancer stem cells. He has initiated this work with a grant he received from the National Research Council of Sri Lanka, 2014. The National Science Foundation has provided financial support for the current development work.
He added that any Sri Lankan who lives abroad can also contribute their research work financially. “Depending on the funds we have we are planning to include our new drug candidate in clinical trials,”
he added.
Sathasivam Friday, 25 May 2018 03:01 PM
This is what we need to the Country today,go ahead our Intellectuals wish to end up in Nobel prize and serve the suffering cancer patients. Our wishes and pray for the breakthrough success.
Add comment
Comments will be edited (grammar, spelling and slang) and authorized at the discretion of Daily Mirror online. The website also has the right not to publish selected comments.
Reply To:
Name - Reply Comment
The country’s health sector has recently witnessed allegations of massive c
Having passed the Sri Lanka Education Administrative Service Exam in 1988, Mr
History was made on July 26, 2023, when Sri Lanka-born Gary Anandasangaree wa
22 Sep 2023
28 minute ago
3 hours ago
3 hours ago